Home  >  Products  >  ICOSLG (inducible T-cell co-stimulator ligand ) Blocking Peptide (the N terminal of ICOSLG)(100ug)
ICOSLG (inducible T-cell co-stimulator ligand ) Blocking Peptide (the N terminal of ICOSLG)(100ug)

ICOSLG (inducible T-cell co-stimulator ligand ) Blocking Peptide (the N terminal of ICOSLG)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ICOSLG Antibody (ARP64016_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64016
Size: 100ug
Weight: 33kDa
Gene: 23308
Format: Lyophilized powder
Target: ICOSLG is a ligand for the T-cell-specific cell surface receptor ICOS. ICOSLG acts as a costimulatory signal for T-cell proliferation and cytokine secretion; induces also B-cell proliferation and differentiation into plasma cells. ICOSLG could play an important role in mediating local tissue responses to inflammatory conditions, as well as in modulating the secondary immune response by co-stimulating memory T-cell function.
Alternative names: B7-H2; B7H2; B7RP-1; B7RP1; CD275; GL50; ICOS-L; ICOSL; KIAA0653; LICOS
See Full Product Listings >